NO172285C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydraziderInfo
- Publication number
- NO172285C NO172285C NO885830A NO885830A NO172285C NO 172285 C NO172285 C NO 172285C NO 885830 A NO885830 A NO 885830A NO 885830 A NO885830 A NO 885830A NO 172285 C NO172285 C NO 172285C
- Authority
- NO
- Norway
- Prior art keywords
- group
- carbon atoms
- chloro
- preparation
- represents hydrogen
- Prior art date
Links
- FHQAWINGVCDTTG-UHFFFAOYSA-N 4-chloro-3-sulfamoylbenzoic acid Chemical compound NS(=O)(=O)C1=CC(C(O)=O)=CC=C1Cl FHQAWINGVCDTTG-UHFFFAOYSA-N 0.000 title 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- -1 cyano, benzoyl Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000000894 saliuretic effect Effects 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU876131A HU207051B (en) | 1987-12-30 | 1987-12-30 | Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO885830D0 NO885830D0 (no) | 1988-12-30 |
| NO885830L NO885830L (no) | 1989-07-03 |
| NO172285B NO172285B (no) | 1993-03-22 |
| NO172285C true NO172285C (no) | 1993-06-30 |
Family
ID=10971250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO885830A NO172285C (no) | 1987-12-30 | 1988-12-30 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4916149A (cs) |
| EP (1) | EP0324988B1 (cs) |
| JP (1) | JPH01213269A (cs) |
| CN (1) | CN1037336A (cs) |
| AT (1) | ATE75467T1 (cs) |
| AU (1) | AU609682B2 (cs) |
| CA (1) | CA1332739C (cs) |
| CS (1) | CS277585B6 (cs) |
| DD (1) | DD283383A5 (cs) |
| DE (1) | DE3870601D1 (cs) |
| DK (1) | DK727488A (cs) |
| ES (1) | ES2034149T3 (cs) |
| FI (1) | FI886045A7 (cs) |
| GR (1) | GR3004471T3 (cs) |
| HU (1) | HU207051B (cs) |
| IE (1) | IE63246B1 (cs) |
| IL (1) | IL88735A (cs) |
| NO (1) | NO172285C (cs) |
| NZ (1) | NZ227481A (cs) |
| PH (1) | PH25739A (cs) |
| PL (2) | PL157971B1 (cs) |
| PT (1) | PT89368B (cs) |
| RU (2) | RU1838303C (cs) |
| SU (1) | SU1736339A3 (cs) |
| UA (1) | UA19123A (cs) |
| YU (1) | YU47125B (cs) |
| ZA (1) | ZA889729B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE153500T1 (de) * | 1991-04-01 | 1997-06-15 | Univ Duke | Verfahren zur inhibierung der fibrose |
| FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
| DE10132896A1 (de) * | 2001-07-06 | 2003-01-16 | Bayer Cropscience Ag | Heterocyclische Amidderivate |
| DE102005002130A1 (de) * | 2005-01-17 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1122541B (de) * | 1959-12-28 | 1962-01-25 | Hoechst Ag | Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren |
| DE1158927B (de) * | 1961-09-15 | 1963-12-12 | Werner Rahms | Grubenstempel |
| DE2144908C2 (de) * | 1971-09-08 | 1982-12-09 | Hoechst Ag, 6000 Frankfurt | 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung |
| BE793718A (fr) * | 1972-01-07 | 1973-07-05 | Merck & Co Inc | Aminobenzimidazoles |
| DE2247828A1 (de) * | 1972-09-29 | 1974-04-04 | Hoechst Ag | Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung |
| US4420487A (en) * | 1978-04-10 | 1983-12-13 | The Purdue Frederick Company | Diuretic and antihypertensive benzimidazoles |
-
1987
- 1987-12-30 HU HU876131A patent/HU207051B/hu not_active IP Right Cessation
-
1988
- 1988-12-20 IL IL88735A patent/IL88735A/xx not_active IP Right Cessation
- 1988-12-22 NZ NZ227481A patent/NZ227481A/en unknown
- 1988-12-23 DD DD88323775A patent/DD283383A5/de not_active IP Right Cessation
- 1988-12-28 PH PH37991A patent/PH25739A/en unknown
- 1988-12-29 CA CA000587184A patent/CA1332739C/en not_active Expired - Fee Related
- 1988-12-29 ZA ZA889729A patent/ZA889729B/xx unknown
- 1988-12-29 JP JP63335692A patent/JPH01213269A/ja active Pending
- 1988-12-29 DK DK727488A patent/DK727488A/da not_active Application Discontinuation
- 1988-12-29 US US07/295,925 patent/US4916149A/en not_active Expired - Fee Related
- 1988-12-30 YU YU240188A patent/YU47125B/sh unknown
- 1988-12-30 PL PL1988276889A patent/PL157971B1/pl unknown
- 1988-12-30 EP EP88121901A patent/EP0324988B1/de not_active Expired - Lifetime
- 1988-12-30 CN CN88108996A patent/CN1037336A/zh active Pending
- 1988-12-30 SU SU884613207A patent/SU1736339A3/ru active
- 1988-12-30 IE IE389288A patent/IE63246B1/en not_active IP Right Cessation
- 1988-12-30 PL PL1988282492A patent/PL158049B1/pl unknown
- 1988-12-30 AU AU27631/88A patent/AU609682B2/en not_active Ceased
- 1988-12-30 UA UA4613207A patent/UA19123A/uk unknown
- 1988-12-30 DE DE8888121901T patent/DE3870601D1/de not_active Expired - Lifetime
- 1988-12-30 CS CS889108A patent/CS277585B6/cs unknown
- 1988-12-30 AT AT88121901T patent/ATE75467T1/de not_active IP Right Cessation
- 1988-12-30 NO NO885830A patent/NO172285C/no unknown
- 1988-12-30 FI FI886045A patent/FI886045A7/fi not_active Application Discontinuation
- 1988-12-30 PT PT89368A patent/PT89368B/pt not_active IP Right Cessation
- 1988-12-30 ES ES198888121901T patent/ES2034149T3/es not_active Expired - Lifetime
-
1989
- 1989-05-10 RU SU894613991A patent/RU1838303C/ru active
- 1989-10-20 RU SU894742151A patent/RU1830064C/ru active
-
1992
- 1992-04-30 GR GR920400738T patent/GR3004471T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO941592L (no) | Adhesjonsreseptorantagonister | |
| NO972615D0 (no) | Benzimidazolderivater | |
| NZ222398A (en) | Sulphone compounds containing peroxycarboxylic acid groups; and bleaching compositions | |
| ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
| AU541413B2 (en) | 2-(1,4-benzodioxan-2-ylalicyl)imidazoles | |
| NO172285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-klor-3-sulfamoylbenzosyrehydrazider | |
| ES2038668T3 (es) | Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica. | |
| KR860001808A (ko) | 이미다조〔1,5-a〕피리미딘 유도체의 제조방법 | |
| ES477785A1 (es) | Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas. | |
| PT1051393E (pt) | Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos | |
| FI871637A0 (fi) | Foerfarande foer framstaellning av 1,5-benzotiazepinderivat. | |
| CS387391A3 (en) | Phenylalkylaminoalkyl compounds, process of their preparation andmedicaments comprising said compounds | |
| CA2308315A1 (en) | N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents | |
| AU586477B2 (en) | Hexenoic acids | |
| ES539656A0 (es) | Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas. | |
| EP0663384A3 (de) | Salze der Pyromellitsäure, ein Verfahren zu ihrer Herstellung sowie deren Verwendung. | |
| FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
| IE841441L (en) | 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols. |